Display Settings:

Format

Send to:

Choose Destination
    Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug;40(4):416-8.

    Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II.

    Source

    Albert Einstein College of Medicine, Pelham Bay, NY 10461, USA.

    Erratum in

    • Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):547.

    Abstract

    A 29-year-old woman with membranoproliferative glomerulonephritis type II presented with decreased vision due to choroidal neovascular membrane. She was treated with monthly intravitreal injections of bevacizumab. Although there was dramatic improvement in her vision after the third injection, it continued to improve through the ninth monthly injection. Despite recent reports of renal side effects of systemic bevacizumab, patients with preexisting renal disease treated by the authors did not demonstrate any loss of renal function 1 year after treatment.

    PMID:
    19634750
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk